| Nr. | Year OPEN | Title | users say | rate good | rate bad | no link | Citation |
|---|
Apolipoprotein BApolipoprotein AIAMD macular degenerationRetina (BASKET)SteatohepatosisLipoprotein (VLDL)Microsomal triglyceride transfer proteinAPOBECAntibodies (Immungenetics)AID cytidine deaminaseAPOBEC1| 1 | 2005 | Apolipoprotein B: a clinically important apolipoprotein which assembles atherogenic lipoproteins and promotes the development of atherosclerosis. | 
| + | - | nl | J Intern Med 258(5):395-410 (2005) Olofsson SO |
| 2 | 2007 | Apolipoproteins A-I and B: biosynthesis, role in the development of atherosclerosis and targets for intervention against cardiovascular disease. |
| + | - | nl | Vasc Health Risk Manag 3(4):491-502 (2007) Olofsson SO |
| 3 | 2001 | Structure of apolipoprotein B-100 in low density lipoproteins. |
| + | - | nl | J Lipid Res 42(9):1346-67 (2001) |
| 4 | 1990 | Familial defective apolipoprotein B-100: a mutation of apolipoprotein B that causes hypercholesterolemia. |
| + | - | nl | J Lipid Res 31(8):1337-49 (1990) |
| 5 | 2009 | The ever-expanding role of degradation in the regulation of apolipoprotein B metabolism. |
| + | - | nl | J Lipid Res 50 Suppl(-):S162-6 (2009) |
| 6 | 2010 | Apolipoprotein B-containing lipoproteins in retinal aging and age-related macular degeneration. |
| + | - | nl | J Lipid Res 51(3):451-67 (2010) |
| 7 | 2011 | Novel findings for the development of drug therapy for various liver diseases: Liver microsomal triglyceride transfer protein activator may be a possible therapeutic agent in non-alcoholic steatohepatitis. | 
| + | - | nl | J Pharmacol Sci 115(3):270-3 (2011) |
| 8 | 2008 | The AID/APOBEC family of nucleic acid mutators. |
| + | - | nl | Genome Biol 9(6):229 (2008) |
